'Charging down the wrong path'
Is cancer a metabolic, epigenetic disease?
Date: Saturday 19th November
Time: 9.30 am to 5.00 pm
Venue: Woburn House Conference Centre, London WC1H 9HQ
Cancer, according to the mainstream view, is the result of a few damaging mutations in the genes of a cell, so research and treatment focus on identifying those genes and targeting them with drugs.
Increasingly this picture is looking badly flawed. It misses another important defect in cancer cells. Their metabolism - the way they make energy –is damaged. So targeting tumour genes plus energy supply could make treatment more effective. In the USA the metabolic theory is attracting growing scientific interest.
Many complementary cancer treatments are designed to create conditions in the body that are unfavourable to cancer growth. Metabolic theory fits these approaches into a bigger picture.
Paul Davies the Principal Investigator in the center for the Convergence of Physical Science and Cancer Biology at Arizona State University will open the Yes to Life Annual Conference CPD accredited conference by video. He describes the exclusive focus on rogue genes as ‘charging down the wrong path'. He introduced the metabolic theory and described how it fits with creating a more cancer-hostile internal environment.
Travis Christofferson, the American researcher and bestselling author of 'Tripping over the Truth,’ published last year, talked about the history of the metabolic theory – first proposed nearly a hundred years ago and then ignored. He described the serious flaws emerging in the gene theory and how this has paved the way for a comeback by the metabolic theory .
Travis was joined by:
Dr Robert Verkerk, Founder of ANH International who covered the developing science behind metabolic theory.
Dr Ndaba Mazibuko, Clinical Research Fellow at King's College London who talked about metabolic approaches in clinical practice. Dr Mazibuko is collaborating with The Seek Group and The Care Oncology Clinic in the area of metabolic repurposed drug analysis for people with cancer.
Patricia Daly talked about 'Ketogenics – a way of targeting cancer cells’ faulty metabolism with diet'.
Jane McLelland shared her personal story of her successful use of off-label drugs and other treatments that tackled vulnerabilities in tumours revealed by the metabolic theory and received a standing ovation. Hardly a dry eye in the house.
Extensive Q&A sessions were held.